Neill, A.
6 November, 2015
This presentation describes key clinical features of OSA, its prevalence, ethnic and geographical distribution in New Zealand, disease burden, societal cost, and the cost effectiveness of current treatments. Presented to Respiratory Conference New Zealand in November 2015.
Jurgens, K.
5 November, 2015
The first step in asthma treatment is prescription of Ventolin, a β-2 agonist. Access to this drug is currently by prescription only in New Zealand, but not in Australia and some other countries. Kirk examines both approaches in order to encourage serious contemplation of how we think about asthma and the medications we use to control it.
McNaughton, A
5 November, 2015
The Sing Your Lungs Out study has looked at the impact that participation in a community singing group has on the respiratory function and health of patients with COPD. Presented to the Respiratory Conference New Zealand in November 2015
Jones, B., Walters, L., Maiava, V., Nathan, M.
5 November, 2015
This Māori Engagement Project used a participatory action research (PAR) methodology within a kaupapa Māori research (KMR) framework. Māori nurses from three regions were chosen as asthma nurse champions to drive the research and develop innovations. Presented to Respiratory Conference New Zealand, November 2015
Ingham, T and Davies, C.
5 November, 2015
Presentation to Respiratory Conference New Zealand November 2015
Bosnic-Anticevic, S.
5 November, 2015
The role of medications in the management of asthma is central to good asthma control, and this is reflected in asthma management guidelines globally. However, when it comes to the management of asthma medicine use in practice, there are significant issues associated with the inappropriate use of inhaled medications.
Beasley, R.
5 November, 2015
Presentation to Respiratory Conference New Zealand November 2015
Callahan, D
5 November, 2015
Presentation to Respiratory Conference New Zealand November 2015.
23 December, 2015
2 October, 2015
